Stay updated with breaking news from Alit Taher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First disclosure from Phase 3 COMMANDS study, selected for both ASCO’s official press program and EHA’s plenary session, highlights potential of Reblozyl as first-line treatment of... | May 11, 2023
11.05.2023 - Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, the European Hematology Association (EHA) Congress, and the International Conference on Malignant ...
/PRNewswire/ -- Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the...
/PRNewswire/ -- The non-transfusion-dependent (NTD) form of β-thalassemia, an inherited blood disorder with impaired production of hemoglobin, is characterized...
![European Hematology Association - Above and BEYOND: Luspatercept is [...] - Vimarsana News](https://www.cataniaoggi.it/img/logo_social.jpg){kind=logo}
Salute-e-benessereTHE HAGUE, Netherlands, June 11, 2021 /PRNewswire/ -- The non-transfusion-dependent (NTD) form of [...]